Parametric Portfolio Associates’s Cardlytics CDLX Stock Holding History

Parametric Portfolio Associates’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.92M	Sell	3,498 -322	-8%	-$195K	﹤0.01%	2438
2021 Q4	$2.52M	Buy	3,820 +674	+21%	+$515K	﹤0.01%	2304
2021 Q3	$2.64M	Buy	3,146 +666	+27%	+$676K	﹤0.01%	2270
2021 Q2	$3.15M	Sell	2,480 -2,268	-48%	-$2.56M	﹤0.01%	2162
2021 Q1	$5.21M	Sell	4,748 -1,635	-26%	-$2.16M	﹤0.01%	2143
2020 Q4	$9.11M	Buy	6,383 +1,531	+32%	+$1.63M	0.01%	1638
2020 Q3	$3.42M	Sell	4,852 -221	-4%	-$161K	﹤0.01%	2155
2020 Q2	$3.55M	Buy	5,073 +2,887	+132%	+$1.67M	﹤0.01%	2121
2020 Q1	$764K	Sell	2,186 -1,971	-47%	-$1.4M	﹤0.01%	2948
2019 Q4	$2.61M	Sell	4,157 -1,107	-21%	-$541K	﹤0.01%	2518
2019 Q3	$1.76M	Buy	+5,264	New	+$1.69M	﹤0.01%	2708

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

ACM

Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JCM

JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return

Parametric Portfolio Associates's CDLX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Cardlytics (CDLX) stake by 8.4% in Q1 2022, selling an estimated $195K and leaving 3,498 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Parametric Portfolio Associates first reported a position in CDLX in Q3 2019 and has held it in 11 quarters since. The position peaked at $9.11M in Q4 2020. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.

Parametric Portfolio Associates held 3,498 shares of Cardlytics worth $1.92M as of Q1 2022.
Parametric Portfolio Associates sold 322 Cardlytics shares in Q1 2022, an estimated $195K.
Cardlytics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2438 holding.
Parametric Portfolio Associates first reported a position in Cardlytics in Q3 2019 and has held it in 11 quarters since.
Parametric Portfolio Associates's Cardlytics position peaked at $9.11M in Q4 2020.
153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.